ArticleBrain communications2022

No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study.

Rishi J Desai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.